Super-Refractory Status Epilepticus in Children: A Retrospective Cohort Study

Area of Science:

• Neurology
• Pediatric Critical Care

Background:

• Super-refractory status epilepticus (SRSE) is a rare but severe neurological emergency in children.
• Characterizing the pediatric SRSE population is crucial for understanding treatment variability and outcomes.

Purpose of the Study:

• To compare clinical characteristics and outcomes between pediatric SRSE and non-SRSE patients.
• To describe treatment variability within the pediatric SRSE population.

Main Methods:

• Retrospective cohort study using prospectively collected data from 17 US academic hospitals (June 2011-January 2019).
• Included pediatric patients (1 month-21 years) with convulsive refractory status epilepticus.
• Defined SRSE as seizures lasting ≥24 hours after continuous infusion initiation.

Main Results:

• 31 SRSE patients were identified among 281 total.
• SRSE patients experienced delayed initiation of non-benzodiazepine antiseizure medications and continuous infusions.
• SRSE was associated with prolonged seizure duration, longer ICU stays, more medical complications, lower return to baseline function, and higher mortality.
• Treatment for SRSE was heterogeneous, with varying numbers of continuous infusions required for resolution.

Conclusions:

• Pediatric SRSE patients face worse outcomes, including higher mortality and complications, compared to non-SRSE patients.
• Delayed treatment initiation and heterogeneous therapeutic approaches characterize pediatric SRSE.
• Further research is needed to establish evidence-based guidelines for managing pediatric SRSE.